D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$1.2B |
| 2 |
Boston Scientific
BSX
|
+$1.05B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$934M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$924M |
| 5 |
JPMorgan Chase
JPM
|
+$922M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.2B |
| 2 |
NVIDIA
NVDA
|
+$1.58B |
| 3 |
Palantir
PLTR
|
+$901M |
| 4 |
Netflix
NFLX
|
+$883M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$805M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 30.42% |
| 2 | Technology | 18.55% |
| 3 | Consumer Discretionary | 8.97% |
| 4 | Financials | 8.5% |
| 5 | Healthcare | 8.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
201
CALL
Oracle
ORCL
$429B
| $184M | 0.11% |
1,253,800
+1,139,500
| +997% | +$185M |
2022 Q3
14 quarters
|
|
|
CRWV
202
PUT
CoreWeave
CRWV
$45.3B
| $184M | 0.11% |
2,376,400
+1,631,700
| +219% | +$142M |
2025 Q4
1 quarter
|
|
203
Applied Optoelectronics
AAOI
$9.31B
| $179M | 0.11% |
2,117,157
+750,301
| +55% | +$47.9M |
2025 Q4
1 quarter
|
|
204
Wells Fargo
WFC
$253B
| $179M | 0.11% |
2,243,244
-653,874
| -23% | -$56.2M |
2013 Q2
51 quarters
|
|
205
PUT
Marvell Technology
MRVL
$247B
| $178M | 0.11% |
1,802,100
-1,470,000
| -45% | -$123M |
2022 Q4
13 quarters
|
|
206
Bath & Body Works
BBWI
$3.5B
| $177M | 0.11% |
9,504,593
+3,735,358
| +65% | +$80.8M |
2025 Q2
3 quarters
|
|
207
Citizens Financial Group
CFG
$26.8B
| $177M | 0.11% |
2,957,561
+1,764,433
| +148% | +$108M |
2023 Q2
11 quarters
|
|
208
PUT
lululemon athletica
LULU
$10.9B
| $176M | 0.11% |
1,152,100
-37,200
| -3% | -$6.67M |
2013 Q2
51 quarters
|
|
209
Unity
U
$20.6B
| $176M | 0.11% |
8,018,061
+4,727,277
| +144% | +$131M |
2024 Q2
7 quarters
|
|
210
Veeva Systems
VEEV
$47.9B
| $176M | 0.11% |
999,755
+600,354
| +150% | +$118M |
2025 Q2
3 quarters
|
|
211
State Street SPDR S&P Biotech ETF
XBI
$10B
| $175M | 0.11% |
1,367,792
+630,015
| +85% | +$78.6M |
2025 Q4
1 quarter
|
|
212
ICICI Bank
IBN
$100B
| $174M | 0.1% |
6,712,676
+792,467
| +13% | +$23.2M |
2025 Q1
4 quarters
|
|
213
Spotify
SPOT
$109B
| $174M | 0.1% |
358,473
-408,942
| -53% | -$205M |
2018 Q2
31 quarters
|
|
|
214
CALL
Broadcom
AVGO
$1.73T
| $174M | 0.1% |
561,000
+346,000
| +161% | +$114M |
2021 Q1
20 quarters
|
|
215
CALL
Goldman Sachs
GS
$261B
| $173M | 0.1% |
204,600
-81,600
| -29% | -$72.8M |
2013 Q2
51 quarters
|
|
216
Elastic
ESTC
$10.3B
| $173M | 0.1% |
3,462,254
+1,472,778
| +74% | +$90.5M |
2025 Q2
3 quarters
|
|
217
Shopify
SHOP
$220B
| $173M | 0.1% |
1,454,594
+174,425
| +14% | +$22.9M |
2023 Q1
12 quarters
|
|
218
PUT
Robinhood
HOOD
$98B
| $173M | 0.1% |
2,489,300
+1,100,800
| +79% | +$96.6M |
2023 Q4
9 quarters
|
|
219
CALL
Eli Lilly
LLY
$1.05T
| $171M | 0.1% |
185,700
-80,600
| -30% | -$81.7M |
2018 Q2
31 quarters
|
|
220
CALL
Iris Energy
IREN
$13.9B
| $170M | 0.1% |
4,959,600
-798,500
| -14% | -$36.1M |
2025 Q3
2 quarters
|
|
|
221
PUT
Alphabet (Google) Class A
GOOGL
$4.3T
| $170M | 0.1% |
591,000
-1,300,400
| -69% | -$409M |
2018 Q1
32 quarters
|
|
222
TJX Companies
TJX
$153B
| $168M | 0.1% |
1,054,889
-293,840
| -22% | -$45.8M |
2013 Q2
51 quarters
|
|
223
Astera Labs
ALAB
$59.4B
| $167M | 0.1% |
1,519,561
-932,819
| -38% | -$133M |
2024 Q4
5 quarters
|
|
224
Vaxcyte
PCVX
$10.6B
| $167M | 0.1% |
2,865,318
-765,735
| -21% | -$41.6M |
2022 Q4
13 quarters
|
|
225
PUT
Rogers Communications
RCI
$16.1B
| $166M | 0.1% |
4,314,600
+952,200
| +28% | +$36.3M |
2023 Q2
11 quarters
|
|
Similar funds
D.E. Shaw & Co's Q1 2026 Portfolio in Review
As of Q1 2026, D.E. Shaw & Co held 5,226 positions worth $166B, down 8.8% from $182B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
D.E. Shaw & Co withdrew a net $5.92B in Q1 2026, closing 756 positions and reducing 1,922 holdings. Its most notable exit was iShares Core S&P 500 ETF, an estimated $805M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 30% of assets, down from 36% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, D.E. Shaw & Co opened a new position in Venture Global Inc worth $211M.
- D.E. Shaw & Co's largest Q1 2026 buy was Venture Global Inc: 13,410,074 shares worth $211M.
- D.E. Shaw & Co added most to Broadcom in Q1 2026, an estimated $1.2B increase.
- D.E. Shaw & Co's biggest Q1 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $3.2B.
- D.E. Shaw & Co fully exited iShares Core S&P 500 ETF in Q1 2026, selling an estimated $805M.
- D.E. Shaw & Co's ten largest holdings make up 11% of its $166B portfolio in Q1 2026.
- D.E. Shaw & Co opened 685 new positions and closed 756 in Q1 2026.
- D.E. Shaw & Co's portfolio value fell 8.8% quarter-over-quarter to $166B.
Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.